Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,858.00
Bid: 6,847.00
Ask: 6,850.00
Change: 1.00 (0.01%)
Spread: 3.00 (0.04%)
Open: 6,800.00
High: 6,921.00
Low: 6,779.00
Yest. Close: 6,857.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UK approves Pfizer-BioNTech vaccine for use

LONDON, Dec 2 (Reuters) - Britain on Wednesday said it had approved the Pfizer-BioNTech vaccine for use and that it will be rolled out for use from next week."The Government has today accepted the recommendation from the independent Medicines and ...

2 Dec 20 07:00

GLOBAL MARKETS-Global equity markets jump, bonds dip, on hopes of vaccine-led recovery

(Updates through midday U.S. trading)By David RandallNEW YORK, Dec 1 (Reuters) - Stock markets rose and safe havens such as U.S. Treasury bonds dipped Tuesday as better-than-expected factory data and signs that the first coronavirus vaccinations c...

1 Dec 20 17:06

AstraZeneca partner sticks with two full dose regimen in COVID trials in India

* Half-dose, full-dose could complicate vaccine distribution-SII* SII sees factors beyond efficacy as crucial in vaccine decisions* SII sees affordability, ease of storage and transport as keyBy Abhirup Roy and Euan RochaPUNE, Dec 1 (Reuters) - Se...

1 Dec 20 15:45

UPDATE 1-After 4.2 million COVID-19 cases in November, U.S. pins hope on vaccine

(Adds Ohio governor, travel data)WASHINGTON, Dec 1 (Reuters) - The United States entered the final month of the year with expectations that promising vaccine candidates will soon be approved to halt the rapidly spreading coronavirus after 4.2 mill...

1 Dec 20 15:16

REFILE-After 4.2 million COVID-19 cases in November, U.S. pins hope on vaccine

(Deletes extraneous "refuse to" in 2nd paragraph)WASHINGTON, Dec 1 (Reuters) - The United States entered the final month of the year hoping that promising vaccine candidates will soon be approved to halt the rapidly spreading novel coronavirus aft...

1 Dec 20 15:10

GLOBAL MARKETS-Global equities jump, bonds dip, on hopes of vaccine-led recovery

By David RandallNEW YORK, Dec 1 (Reuters) - Stock markets rose and safe havens such as U.S. Treasury bonds dipped Tuesday as better than expected factory data and signs that the first coronavirus vaccinations could be administered by the end of th...

1 Dec 20 14:56

GLOBAL MARKETS-World shares rise on recovery hopes after record November

(Adds details, updates prices, changes dateline)* World shares up 0.4%, U.S. futures up sharply* Vaccine hopes drives optimism after EZ factory recovery falters* China factory activity growth hits decade high in November* U.S. dollar weakens, Bitcoi...

1 Dec 20 13:47

Bangladesh expects to receive first COVID vaccines by February

DHAKA, Dec 1 (Reuters) - Bangladesh expects to receive its first batch of coronavirus vaccines by February which people will receive free of charge, the health secretary said on Tuesday.The South Asian country of more than 160 million last month ...

1 Dec 20 13:16

After 4.2 million COVID-19 cases in November, U.S. pins hope on vaccine

WASHINGTON, Dec 1 (Reuters) - The United States entered the final month of the year hoping that promising vaccine candidates will soon be approved to halt the rapidly spreading novel coronavirus after 4.2 million new cases were reported in Novemb...

1 Dec 20 12:54

CORRECTED-After 4.2 million COVID-19 cases in November, U.S. pins hope on vaccine

(Corrects details of vaccine approval procedure, third paragraph)WASHINGTON, Dec 1 (Reuters) - The United States entered the final month of the year hoping that promising vaccine candidates will soon be approved to halt the rapidly spreading novel...

1 Dec 20 12:54

UPDATE 1-Pfizer-BioNTech seek EU emergency approval for COVID-19 vaccine, target Dec rollout

* Pfizer, BioNTech request EU conditional approval* Raises prospect of European launch this month* Rival Moderna has said it is nearing an EU filing* Pfizer-BioNTech sought U.S. emergency nod in Nov (Adds background on pandemic, companies quote)By L...

1 Dec 20 11:09

UPDATE 2-COVID-19 vaccine sprint as Pfizer-BioNTech, Moderna seek emergency EU approval

* Pfizer, BioNTech request EU conditional approval* Regulator says panel to meet Dec 29 at latest* Rival Moderna also submits EU filing for its shot* Both groups have applied for U.S. emergency use (Adds review timing, details on Moderna request)By ...

1 Dec 20 11:09

UPDATE 3-COVID-19 vaccine sprint as Pfizer-BioNTech, Moderna seek emergency EU approval

* Pfizer, BioNTech request EU conditional approval* Regulator says panel to meet Dec 29 at latest* Rival Moderna also submits EU filing for its shot* Both groups have applied for U.S. emergency use (Adds EMA starting rolling review of J&J candidate)...

1 Dec 20 11:09

Pfizer-BioNTech apply for EU emergency authorization for COVID-19 vaccine

FRANKFURT, Dec 1 (Reuters) - Pfizer Inc and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, following similar steps in the United States and Britain, the companies said on Tuesday.Th...

1 Dec 20 10:00

LONDON MARKET OPEN: Stocks Look To Build On Strong November Gains

LONDON MARKET OPEN: Stocks Look To Build On Strong November Gains

1 Dec 20 08:53

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.